• Recent news

  • ISO 13485 Approvals in Biotec Pharmacon

    (Tromsø 16. January 2018) ArcticZymes has achieved its first ISO13485 accreditation while Biotec BetaGlucan’s renews its longstanding ISO13485 accreditation follow recent review and approval. Achieving ISO13485 certification is a key milestone for ArcticZymes in elevating its quality standard. This will become increasingly important as the regulatory authorities tighten up regulations on diagnostic…

    Continue reading

Latest presentation

Third quarter 2017 results

Loading video...

Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 14.4 million (21.1) in the third quarter of 2017, and a negative EBITDA of NOK 7.3 million (-5.9). Woulgan® generated sales of NOK 0.4 million during the third quarter. ArcticZymes had a slight reduction in sales compared to third quarter last year…

View more